誉衡药业 (002437)
HARBIN GLORIA PHARMACEUTICALS Co., LTD
K-Line Chart
No K-line data available
Company NameHarbin Yuliang Pharmaceutical Co., Ltd.
Listing Date2010-06-23
Issue Price50RMB
Registered Capital223202.812610k RMB
Legal RepresentativeGuo Leifeng
Registered AddressNo. 29 Beijing Road, Limin Economic and Technological Development Zone, Hulan District, Harbin City, Heilongjiang Province
IndustryChemical Pharmaceuticals
Main BusinessPharmaceutical production and pharmaceutical agency sales.
Company ProfileHarbin Yuliang Pharmaceutical Co., Ltd. is a high-tech enterprise group focusing on the pharmaceutical and health industry, with pharmaceutical manufacturing as its core business, covering research and development, production, marketing, and other fields. The company is recognized by the Ministry of Science and Technology as one of the 'First Batch of Key Enterprises in the National Torch Plan New Pharmaceutical Industry Base'; designated as a 'High-tech Enterprise' by the Heilongjiang Provincial Government; ranked among the 'Top 100 Chinese Pharmaceutical Enterprises in 2016' by the China Pharmaceutical Industry Information Center; selected as one of the 'Top 20 Most Competitive Listed Pharmaceutical Companies in China' by the China Pharmaceutical Enterprise Management Association; and recognized as one of the 'Top 100 Comprehensive Strength Industrial Enterprises in China's Chemical Pharmaceutical Industry in 2017' by multiple industry associations including the China Chemical Pharmaceutical Industry Association, while also receiving the title of 'Growth-oriented Excellent Enterprise Brand'.
Stock Details
1. Key Indicators
- Total Shares(W): 223202.81
- Circulating A-Shares(W): 209922.83
- Earnings Per Share(RMB): 0.1111
- Net Assets Per Share(RMB): 0.9605
- Operating Revenue(W RMB): 166499.73
- Total Profit(W RMB): 26933.33
- Net Profit Attributable to Parent(W RMB): 24376.30
- Net Profit Growth Rate(%): 32.85
- Weighted Return on Equity(%): 11.9300
- Operating Cash Flow Per Share(RMB): 0.1370
- Undistributed Profit Per Share(RMB): -0.1946
- Capital Reserve Per Share(RMB): 0.1857
2. Main Business
The main business covers:
- Research, development, production and sales of pharmaceuticals
3. Company Basic Information
- Company Name: Harbin Gloria Pharmaceuticals Co., Ltd.
- Listing Date: 2010-06-23
- Industry: Pharmaceutical Manufacturing
- Address: Building 28, Ronghui Garden, Yuhua Road, Zone B, Airport Development Zone, Shunyi District, Beijing
- Website: www.gloria.cc
- Company Profile: The Company was established as a joint stock company with foreign investment upon approval by the Ministry of Commerce of the People's Republic of China under the document Shang Zi Pi [2008] No. 659. It was converted from Gloria Limited based on the audited net assets of RMB 109,119,070.29 as of April 30, 2008, at a ratio of 1:0.9622 into 105 million shares, with the remaining net assets of RMB 4,119,070.29 retained as capital reserve. The Company completed its industrial and commercial registration change at the Heilongjiang Provincial Administration for Industry and Commerce on June 26, 2008, and obtained the business license with registration number 230000400002254.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Guotai Haitong Securities Co., Ltd. | Broker | 10879.20 | 5.19 |
| 2 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 6636.97 | 3.17 |
| 3 | YU HENG INTERNATIONAL INVESTMENTS CORPORATION | General Legal Person | 5677.81 | 2.71 |
| 4 | ORIENTAL KEYSTONE INVESTMENT LIMITED | General Legal Person | 4290.46 | 2.05 |
| 5 | Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - Fangyuan - Orient No. 12 Private Investment Fund | General Legal Person | 3070.00 | 1.46 |
| 6 | Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - Fangyuan - Orient No. 27 Private Investment Fund | General Legal Person | 3034.98 | 1.45 |
| 7 | Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - Fangyuan - Orient No. 6 Private Investment Fund | General Legal Person | 2843.51 | 1.36 |
| 8 | Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - Fangyuan - Orient No. 22 Private Investment Fund | General Legal Person | 2800.00 | 1.34 |
5. Concept Sectors
- Private Hospital
- Gene Concept
- Vitamin
- Hepatitis Concept
- Innovative Drug
- Margin Trading & Securities Lending
- Heavily Held by Brokers
- Equity Transfer
- Dispersed Equity
- Special Loan
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information